… In this review, we provide an overview of nasal vaccines with a focus on formulation …
Here, we provide examples of intranasal vaccines that are being developed against SARS-CoV-2, …

… In this article, the current approaches used to develop effective oral and nasal mucosal
vaccines against SARS‐CoV‐2 and their benefits, prospects, and challenges have been …

… We recently reported the protective activity of an intranasally … intranasal immunization with
ChAd-SARS-CoV-2-S provides durable protection against historical and emerging SARS-CoV-…

… So far, all the approved vaccines are by intramuscular (IM) injection only, although different
… on development of an intranasal (IN) SARS-CoV-2 vaccine. Ideally a vaccine, at least against …

… hamsters, which are naturally permissive to SARS-CoV-2 replication and closely mirror …
of LV-based vaccination against SARS-CoV-2 and designate intranasal immunization as a …

… 2 virus breaches before dissemination to the lung. We report the development of an intranasal
subunit vaccine … This vaccine induces systemic neutralizing antibodies, IgA in the lung and …

… vaccines to develop antibody enhancement phenomenon. Herein, we report the experimental
immunization of mice by inactivated SARS-CoV … in serum in intranasally immunized mice. …

… vaccine-platforms, which are safe, effective, and can be modified to carry antigens of emerging
pathogens. The current SARS-CoV-2 vaccines … a novel SARS-CoV-2 vaccine candidate …

… While intramuscular vaccination prevented morbidity and cleared SARS-CoV-2 from the …
after challenge, intranasal vaccination was more effective as neither infectious virus nor viral …

… At 3 days after SARS-CoV-2 challenge, intranasally vaccinated hamsters had lower viral …
indicate that intranasal vaccination with an mRNA-LNP SARS-CoV-2 vaccine is protective and …